Back
Amgen 10K Form
Sell
26
AMGN
Amgen
Last Price:
317.28
Seasonality Move:
11.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-08-07 | 10Q | AMGN/Amgen Quarterly |
| 2024-05-03 | 10Q | AMGN/Amgen Quarterly |
| 2024-02-14 | 10K | AMGN/Amgen Annual |
| 2023-10-31 | 10Q | AMGN/Amgen Quarterly |
| 2023-08-04 | 10Q | AMGN/Amgen Quarterly |
| 2023-04-28 | 10Q | AMGN/Amgen Quarterly |
Receive AMGN News And Ratings
See the #1 stock for the next 7 days that we like better than AMGN
AMGN Financial Statistics
Sales & Book Value
| Annual Sales: | $28.19B |
|---|---|
| Cash Flow: | $2.22B |
| Price / Cash Flow: | 31.03 |
| Annual Sales: | $11.03 |
| Price / Book: | 28.66 |
Profitability
| EPS (TTM): | 5.81000 |
|---|---|
| Net Income (TTM): | $3.13B |
| Gross Margin: | $19.74B |
| Return on Equity: | 49.5% |
| Return on Assets: | 3.39% |
Amgen Earnings Forecast
Key Amgen Financial Ratios
- The Gross Profit Margin over the past 40 years for AMGN is 70.02%.
- The Selling, General & Administrative Expenses for AMGN have been equal to 21.92% of Gross Profit Margin.
- The Research & Development expenses have been 16.97% of Revenue.
- The Interest Expense is 42.80% of Operating Income.
- The Net Earning history of AMGN is 23.83% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 26 years.
Amgen Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AMGN |
| CUSIP: | 031162 |
| Website: | amgen.com |
Debt
| Debt-to-Equity Ratio: | 10.57 |
|---|---|
| Current Ratio: | 1.26 |
| Quick Ratio: | 0.75 |
Price-to-Earnings
| Trailing P/E Ratio: | 25.3 |
|---|---|
| Forward P/E Ratio: | 15.34 |